secwatch.observer — SEC 8-K summary
======================================

Issuer:     KALA BIO, Inc. (KALA)
CIK:        0001479419
Form:       8-K
Filed at:   2025-11-12T23:59:59+00:00
Accession:  0001104659-25-110316
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

KALA BIO receives Nasdaq deficiency notice for MVLS below $35M; 180 days to comply
--------------------------------------------------------------------------------

- Nasdaq notified KALA BIO on Nov 10, 2025 that MVLS was below $35M for 30 consecutive business days, violating Listing Rule 5550(b)(2).
- Company also fails alternative standards: stockholders' equity <$2.5M and no net income from continuing operations in recent fiscal years.
- Has until May 11, 2026 to regain compliance; if MVLS is at least $35M for 10 consecutive days, compliance is restored.
- If not compliant by the deadline, stock subject to delisting; company may appeal to a Nasdaq Listing Qualifications Panel.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479419/000110465925110316/0001104659-25-110316-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479419/000110465925110316/kala-20251110x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-110316

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer